You just read:

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology

News provided by

Innovent Biologics, Inc.

Sep 21, 2018, 00:00 ET